UBS Group’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.13M | Buy |
|
|||||
|
2025
Q2 | $3.14M | Sell |
|
|||||
|
2025
Q1 | $4.33M | Sell |
|
|||||
|
2024
Q4 | $4.06M | Buy |
|
|||||
|
2024
Q3 | $1.51M | Sell |
|
|||||
|
2024
Q2 | $2.9M | Sell |
|
|||||
|
2024
Q1 | $4.97M | Buy |
|
|||||
|
2023
Q4 | $214K | Buy |
|
|||||
|
2023
Q3 | $67.2K | Buy |
|
|||||
|
2023
Q2 | $110K | Sell |
|
|||||
|
2023
Q1 | $208K | Sell |
|
|||||
|
2022
Q4 | $1.87M | Buy |
|
|||||
|
2022
Q3 | $576K | Buy |
|
|||||
|
2022
Q2 | $186K | Sell |
|
|||||
|
2022
Q1 | $971K | Sell |
|
|||||
|
2021
Q4 | $2.16M | Buy |
|
|||||
|
2021
Q3 | $2.71M | Buy |
|
|||||
|
2021
Q2 | $388K | Sell |
|
|||||
|
2021
Q1 | $1.33M | Buy |
|
|||||
|
2020
Q4 | $69K | Sell |
|
|||||
|
2020
Q3 | $72K | Sell |
|
|||||
|
2020
Q2 | $193K | Buy |
|
|||||
|
2020
Q1 | $16K | Sell |
|
|||||
|
2019
Q4 | $37K | Sell |
|
|||||
|
2019
Q3 | $17K | Buy |
|
|||||
|
2019
Q2 | $8K | Sell |
|
|||||
|
2019
Q1 | $19K | Sell |
|
|||||
|
2018
Q4 | $28K | Buy |
|
|||||
|
2018
Q3 | $26K | Sell |
|
|||||
|
2018
Q2 | $149K | Buy |
|
|||||
|
2018
Q1 | $27K | Sell |
|
|||||
|
2017
Q4 | $56K | Buy |
|
|||||
|
2017
Q3 | $62K | Buy |
|
|||||
|
2017
Q2 | $70K | Buy |
|
|||||
|
2017
Q1 | $27K | Buy |
|
|||||
|
2016
Q4 | $14K | Sell |
|
|||||
|
2016
Q3 | $23K | Buy |
|
|||||
|
2016
Q2 | $13K | Sell |
|
|||||
|
2016
Q1 | $24K | Buy |
|
|||||
|
2015
Q4 | $36K | Buy |
|
|||||
|
2015
Q3 | $23K | Buy |
|